English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA two-year study found that spikes of post-vaccination SARS-CoV-2 viral infections (commonly known as COVID-19 breakthrough cases) remain common, yet hospitalization rates have dramatically dropped following the first wave of the virus’ omicron subvariant.
Tag: Organ Transplantation
Icahn School of Medicine at Mount Sinai Researchers Awarded $15.1 Million Grant to Explore Immune Rejection of Transplanted Organs
Striving to improve organ transplant survival rates, internationally renowned researchers in immunology and bioengineering at the Icahn School of Medicine at Mount Sinai have received $15.1 million from the National Institute of Allergy and Infectious Diseases (NIAID) to lead a novel, five-year multi-center research program that will explore trained immunity—the innate immune system’s ability to remember infections and other insults—as a target for preventing organ transplant rejection.
The Medical Minute: Six organ donation facts knock down six myths
More than 100,000 people in the U.S. are awaiting new organs. Many won’t live long enough to get them. The new chief of transplant at Penn State Health Milton S. Hershey Medical Center debunks the myths that get between donors and recipients.
Johns Hopkins Medicine to Receive $21.4 Million to Advance Viability of Animal Organs for Transplants and Enable Human Clinical Trials
As part of the worldwide effort to facilitate a research and clinical pathway toward successful xenotransplantation — the transplantation of living cells, tissues and organs from one species to another — two Johns Hopkins Medicine surgeons, Kazuhiko Yamada, M.D., Ph.D., and Andrew Cameron, M.D., Ph.D., will receive a total of $21.4 million in funding over the next two years under two sponsored research agreements with biotechnology company United Therapeutics Corporation.
Organ Transplants Reached Record Levels at Cleveland Clinic in 2022
Cleveland Clinic performed 1,050 transplants in 2022, including heart, kidney, liver, intestine and lung transplants, as well as living donor transplantation for kidney and liver. That is up 1% from the number of transplants performed at Cleveland Clinic in 2021.
A World First: For the First Time, a Human Liver Was Treated in a Machine and Then Successfully Transplanted
The Liver4Life research team owes its perfusion machine, which was developed in house, to the fact that it became possible to implant a human organ into a patient after a storage period of three days outside a body.
Stanley C. Jordan, MD, Elected to Association of American Physicians
Stanley C. Jordan, MD, director of the Cedars-Sinai Nephrology and Transplant Immunology programs in the Cedars-Sinai Comprehensive Transplant Center, has been elected to the Association of American Physicians (AAP).
Organ Transplant Recipients Significantly Protected by COVID-19 Vaccination
UC San Diego researchers report that solid organ transplant recipients who were vaccinated experienced an almost 80 percent reduction in the incidence of symptomatic COVID-19 compared to unvaccinated counterparts during the same time.
Atlantic Health System and NYU Langone Health Announce Partnership on Organ Transplantation
Two of the leading names in health care in the tri-state region, New Jersey–based Atlantic Health System and New York–based NYU Langone Health, are teaming up to give patients greater access to heart and liver transplants and the coordinated, high-quality care needed to stay healthy. The clinical affiliation will partner NYU Langone’s nationally recognized transplant program with the nationally ranked Atlantic Health System Heart Care program located at Morristown Medical Center’s Gagnon Cardiovascular Institute (Morristown, NJ) and the ground-breaking liver services at Overlook Medical Center (Summit, NJ).
For Transplant Recipients, Third Time May Be the Charm for Better COVID Vaccine Protection
In a study published today in the Annals of Internal Medicine, Johns Hopkins Medicine researchers say they believe that, for the first time, there is evidence to show that three doses of vaccine increase antibody levels against SARS-CoV-2 — the virus that causes COVID 19 — more than the standard two-dose regimen for people who have received solid organ transplants.
Organ Transplant Recipients Remain Vulnerable to Covid-19 Even After Second Vaccine Dose
In a study published today in the Journal of the American Medical Association (JAMA), Johns Hopkins Medicine researchers show that although two doses of a vaccine against SARS-CoV-2 — the virus that causes COVID 19 — confers some protection for people who have received solid organ transplants, it’s still not enough to enable them to dispense with masks, physical distancing and other safety measures.
Are Organ Transplant Recipients at Greater Risk of Death from COVID-19?
A new study analyzes death risk from COVID-19 in organ transplant recipients and finds one treatment method greatly increased the risk.
Liver Transplant Team Part of National Trial to Increase Donor Pool
UC San Diego Health program offers comprehensive care with excellent outcomes Nationally, more than 12,000 people need a liver transplant, including more than 2,300 Californians. Patients can wait several years on the liver transplant wait list in California before receiving…
UC San Diego Health Revives Non-Beating Donor Heart for Successful Transplantation
UC San Diego Health is the first hospital on the West Coast to perform heart transplant surgery from a donor after circulatory death using a new portable organ care system. The investigational procedure could significantly decrease transplant waiting list times and improve patient outcomes.
Hackensack University Medical Center Reactivates Transplant List and Resumes Transplant Surgeries
In March 2020, Hackensack University Medical Center voluntarily inactivated its transplant list and put a hold on performing transplant surgeries due to the coronavirus (COVID-19) pandemic.
Throughout the pandemic, Hackensack University Medical Center’s organ transplant physicians continued to provide care to transplant candidates and previous organ recipients through telehealth virtual visits. Hackensack University Medical Center made the decision to reactivate its transplant list and resume offering transplant procedures now that enhanced patient safety measures designed to prevent the spread of COVID-19 have been successfully implemented across all Hackensack Meridian Health facilities.